Systematic Review
Accepted on 13 Sep 2024
The efficacy and safety of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors combined with statins in patients with hypercholesterolemia: a network meta-analysis
in Cardiovascular Pharmacology and Drug Discovery
- 100 views